BURLINGTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Keystone Dental Holdings, Inc. (“Keystone Dental”), a global commercial stage medical technology company with a comprehensive portfolio of tooth replacement solutions comprised of implants, prosthetic solutions, biomaterial solutions, and digital dentistry capabilities, announced today highlights from the Company’s 2022 Global Interdisciplinary Symposium, hosted in Las Vegas, NV from May 19-21, 2022.

Serving as a customer engagement event and the launch pad for more than 300 new products, Keystone Dental hosted a three-day Symposium, which was attended by more than 600 dental professionals and 45 exhibitors, facilitated by more than 20 industry-leading educators.

In addition, the event included a total of 15 hands-on workshops and 19 scientific sessions that showcased the broad Keystone Dental product portfolio including: Nexus iOS, Genesis, Prima Plus, Paltop, Molaris, and DYNA.

Melker Nilsson, CEO of Keystone Dental, stated, “The Symposium exceeded our expectations. I am proud of our team for executing such a successful event, bringing together our customers and partners, plus many of the most well-respected industry leading influencers to compose an extensive line up of scientific lectures. We are incredibly excited about the continued innovation we can provide to the dental market.”

Concurrently with the event, Keystone Dental introduced its Nexus iOS platform in the U.S., and the launch of the Paltop Dynamic Conical Implant, Torque Calibration Unit, and new Restorative Components.

About Keystone Dental Holdings, Inc. Keystone Dental Group is a global commercial stage medical technology company focused on providing end-to-end solutions for dental practitioners and tooth replacement procedures. Headquartered in Burlington, Massachusetts with a distribution facility in Irvine, California, and a research and development and manufacturing site in Caesarea, Israel and in Melbourne, Australia, Keystone Dental Group markets its products across the world. The Company’s comprehensive portfolio of tooth replacement solutions is comprised of implants, prosthetic solutions, biomaterial solutions and digital dentistry capabilities. It includes proprietary offerings such as Osteon, Nexus iOS, Genesis – The Biomimetic Implant System™, the TILOBEMAXX™, PrimaConnex® and Prima Plus™ Implant Systems, the DynaMatrix® extracellular membrane, and the Dyna Blast® and DynaGraft D® bone graft substitutes. Keystone Dental Group acquired Implant Solutions Pty Ltd (“Osteon”) in 2021, adding a comprehensive portfolio of prosthetic solutions on implants and digital workflow capabilities. For more information, refer to www.keystonedental.com.

Contact: Leigh Salvo Gilmartin Group leigh@gilmartinir.com

Yahoo Finance Live's Seana Smith reports breaking news that EV manufacturer Tesla has filed for a 3-for-1 stock split.

Bridgewater’s co–chief investment officer said the U.S. economy could slow down further.

The rate of U.S. inflation reached a 40-year high of 8.6% in May as overall prices for things including rent, gas and food all remain on the rise. “I personally believe that this inflation is here to stay for quite some time,” Orman recently told CNBC, prior to the release of May’s CPI data from the U.S. Bureau of Labor Statistics. The first is a fixed rate when the purchaser buys the bond, and the second is the inflation adjustment rate, which is reset every six months based on inflation.

(Bloomberg) -- Former Treasury Secretary Lawrence Summers said the Federal Reserve has failed to account for its mistakes and to realize the damage to its credibility after the latest inflation data dashed hopes that a peak had been reached.Most Read from BloombergUS Lifts Covid-19 Test Requirement for International TravelUS Inflation Quickens to 40-Year High, Pressuring Fed and BidenEating Two Portions of Fish Per Week Linked to Deadly Skin CancerFive Key Moments From the Jan. 6 Capitol Riot He

The U.S. hasn't yet entered a recession -- which is officially defined as two consecutive quarters of negative GDP growth -- but runaway inflation, stagnant wages, food shortages, rising interest rates, and geopolitical turmoil could all break this fragile economy's back in the near future. If that happens, growth stocks will fall further as value stocks become even more attractive. Altria is the top tobacco company in America.

In this article, we discuss the 15 best penny stocks to invest in. If you want to skip our analysis of these stocks, go directly to the 5 Best Penny Stocks To Invest In. The US equity market has been volatile since the start of 2022. The Dow 30 Index extended an eight-week consecutive losing […]

The Facebook parent’s lawyers have been investigating outgoing COO Sheryl Sandberg’s use of corporate resources for personal projects going back several years, people familiar with the matter say.

Since taking the reins as CEO of Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) in 1965, Warren Buffett has put on a moneymaking clinic for Wall Street. While there are no shortage of reasons for the Oracle of Omaha's sustained success, his love of dividend stocks could be the most important component. Dividend stocks are almost always profitable and time-tested.

In this article, we discuss 10 beaten-down Asian stocks to buy today. If you want to see more stocks in this selection, click 5 Beaten-Down Asian Stocks to Buy Today. While the US dollar remains strong, Asian markets on June 10 stumbled on the back of higher rates guidance from the European Central Bank and […]

The relaunch will begin on Russia Day, a patriotic holiday celebrating the country's independence, at the same flagship location in Moscow's Pushkin Square where McDonald's first opened in Russia in January 1990. In the early 1990s, as the Soviet Union crumbled, McDonald's came to embody a thawing of Cold War tensions and was a vehicle for millions of Russians to sample American food and culture. The brand's exit is now a powerful symbol of how Russia and the West are once again turning their backs on each other.

Yahoo Finance's Pras Subramanian breaks down the latest news affecting Tesla stock, including more lockdowns in China and the intensifying investigation into the autopilot feature.

Novavax's authorization timeline differs from other first-time applicants, and ongoing submission of manufacturing data has given the FDA reason to slow the process.

Markets are volatile. Use these dividend stocks for peace of mind.

ChargePoint, Autoliv, and QuantumScape look like excellent long-term bets, despite the near-term headwinds they face.

U.S. stocks sank Friday as investors digested two downbeat prints on the U.S. economy.

Lakshman Achuthan, Economic Cycle Research Institute Co-Founder, joins the Live show to discuss the odds of a recession occurring, the causes of a potential downturn, and the outlook for the economy.

What to do in today’s market? The last few trading sessions of declining stocks would seem to indicate that the late-May rally we saw has run its course. But that doesn’t mean the opportunities for buy-minded investors are all gone. The recent declines, and the overall downward trend we’ve seen year-to-date, have left many fundamentally sound stocks trading at rock bottom prices. And that may have created an opportunity for investors willing do a bit of bottom fishing. The trick for investors, h

“Ball of confusion, that's what the world is today,” sang the Temptations on their 1970 classic, a sentiment which can readily apply to the stock market’s present state. It’s hard to get a grip on the market’s choppy action in 2022 and investors could use a clear signal to follow when considering a new investment. One way to get a head start is by tracking the moves of the insiders. These are the corporate officers with in-depth knowledge of the companies they helm. To keep the playing field lev

Be greedy (but selective) when others are fearful.

Moderna's (NASDAQ: MRNA) stock is in poor shape. Unfortunately, when investors take a closer look at why Moderna's stock is so inexpensive, they probably won't want to make that purchase. The most obvious reason Moderna's stock is so cheap is that the market (and public) have moved beyond buying shares of heavily hyped vaccine stocks.